108771 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system; Dendritic cells, e.g. Langherhans cells in the epidermis Immunosuppressive dendritic cells
Methods of Formulating a Vaccine
#2SELECTIVE TOLERIZATION - METHODS OF SELECTIVELY GENERATING TOLEROGENIC DENDRITIC CELLS
#3MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY
#4PREPARATION METHOD OF CITRULLINATED VIMENTIN ANTIGEN-SPECIFIC IMMUNE TOLEROGENIC DENDRITIC CELLS, AND USES THEREOF
#5PREPARATION METHOD OF CITRULLINATED VIMENTIN ANTIGEN-SPECIFIC IMMUNE TOLEROGENIC DENDRITIC CELLS, AND USES THEREOF
#6NF-B signaling pathway-manipulated dendritic cells
#7NOVEL METHOD
#8Hyperactive Dendritic Cells Enable Durable Adoptive Cell Transfer-Based Anti-Tumor Immunity
#9Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders
#10METHOD FOR OBTAINING IMMUNO-SUPPRESSIVE DENDRITIC CELLS
#11THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES
#12OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE
#13METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#14MICROSPHERE-BASED DELIVERY AND EX VIVO MANIPULATION OF DENDRITIC CELLS FOR AUTOIMMUNE THERAPIES
#15PRODUCTION OF ENGINEERED DENDRITIC CELLS AND USES THEREOF
#16DEAD ANTIGEN STIMULATED IMMATURE HETEROGENOUS DENDRITIC CELLS AS THERAPEUTICS FOR DISEASES
#17Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
#18Indole regulation of antigen presenting cells
#19AFFT2 CELL
#20Three-dimensional printed organs, devices, and matrices
#21METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT
#22Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
#23Manipulated immunoregulatory element and immunity altered thereby
#24Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#25Methods for printing organs and organoids
#26TOLEROGENIC DENDRITIC CELLS, METHODS OF PRODUCING THE SAME, AND USES THEREOF
#27NF-KB signaling pathway-manipulated dendritic cells
#28Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
#29ANTI-INFLAMMATORY AGENTS
#30Plasmonic nanoparticle immunoassay method
#31Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
#32Tolerogenic dendritic cells, methods of producing the same, and uses thereof
#33METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#34Granulysin in immunotherapy
#35Galactose oxidase treatment of dendritic cells to improve their immunogenicity
#36Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#37PRODUCTION AND THERAPEUTIC USES OF TH1-LIKE REGULATORY T CELLS
#38METHOD FOR OBTAINING IMMUNO-SUPPRESSIVE DENDRITIC CELLS
#39Tolerogenic dendritic cells, method for their production and uses therof
#40Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
#41Method for generation of regulatory T-cells using factors secreted by iNKT cells
#42ANTI-INFLAMMATORY AGENTS
#43Hydroxylated KRN7000 analogue and use thereof
#44Medicaments and methods for treating mesothelioma
#45Immune tolerance inducer
#46METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#47Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
#48Granulysin in immunotherapy
#49Immunosuppressive cells and methods of making and using thereof
#50CULTURE MEDIUM AND METHOD FOR OBTAINING A POPULATION OF TOLEROGENIC DENDRITIC CELLS
#51NF-κB signaling pathway-manipulated dendritic cells
#52ANTIGEN-PRESENTING CELL POPULATIONS AND THEIR USE AS REAGENTS FOR ENHANCING OR REDUCING IMMUNE TOLERANCE
#53Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#54Method of forming dendritic cells from embryonic stem cells
#55Tolerogenic Plasmacytoid Dendritic Cells Co-Expressing Cd8-Alpha And Cd8-Beta And Methods Of Inducing The Differentiation Of Regulatory T Cells Using Same
#56METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#57USE OF GILZ PROTEIN EXPRESSED IN DENDRITIC CELLS TO MODULATE AN ANTIGEN-SPECIFIC IMMUNE RESPONSE
#58METHODS AND COMPOSITIONS FOR PRODUCING ANTIGENIC RESPONSES
#59Granulysin in immunotherapy
#60Method of forming dendritic cells from embryonic stem cells
#61ANTIGEN-PRESENTING CELL POPULATIONS AND THEIR USE AS REAGENTS FOR ENHANCING OR REDUCING IMMUNE TOLERANCE
#62DENDRITIC CELL MODULATORY MOLECULE
#63Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
#64Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#65PLATFORM OF DENDRITIC CELL (DC)-BASED VACCINATION
#66USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES
#67Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
#68Methods for the early diagnosis of ovarian cancer
#69Method of forming myeloid precursor cells from human embryonic stem cells
#70Therapeutical composition containing dentritic cells and use thereof
#71Method for producing dendritic cells
#72IMMUNOMODULATORY POLYMERIC ANTIGENS FOR TREATING INFLAMMATORY PATHOLOGIES
#73METHOD FOR PRODUCING LANGERHANS CELLS OR INTERSTITIAL DENDRITIC CELLS OR BOTH FROM CD14+ MONOCYTES
#74Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
#75Medicaments and methods for treating mesothelioma
#76Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#77Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance
#78METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE
#79Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell
#80Method for suppressing immune system response to transplanted tissue or cells
#81Tolerogenic populations of dendritic cells
#82RESPIRATORY SYNCYTIAL VIRUS RENDERS DENDRITIC CELLS TOLEROGENIC
#83Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression
#84Tolerogenic dendritic cells, method for their production and uses therof
#85ANTI-CD8 ANTIBODIES BLOCK PRIMING OF CYTOTOXIC EFFECTORS AND LEAD TO GENERATION OF REGULATORY CD8+ T CELLS
#86ILT3 and ILT4-related compositions and methods
#87USES OF BISPECIFIC ANTIBODY COATED DENDRITIC CELLS PULSED WITH ANTIGENS AND GM-CSF IN IMMUNE REGULATION
#88Method for producing dendritic cells
#89Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes
#90Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response
#91Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
#92Antigen specific immunosuppression by dendritic cell therapy
#93Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#94Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
#95DIFFERENT DENDRITIC CELL SUBSETS
#96METHOD OF INDUCING TOLERANCE TO BETAAP 1-42 AND MYELIN BASIC PROTEIN
#97Method for producing dendritic cells
#98Therapeutical Composition Containing Dentritic Cells And Use Thereof
#99Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation
#100Kits to assess the risk of tumor progression
#101Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
#102Method of forming dendritic cells from embryonic stem cells
#103Use of sirnas for gene silencing in antigen presenting cells
#104Dendritic cell presenting a-glycosylceramide derivative and antigent and usable in suppressing immune response
#105Modulation of Fc gamma receptors for optimizing immunotherapy
#106Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#107Immunomodulating compositions, processes for their production and uses therefor
#108Immunomodulation using altered dendritic cells
#109Novel uses of PPAR modulators and professional APCs manipulated by the same
#110Different dendritic cell subsets
#111Tolerogenic antigen-presenting cells
#112Immunotherapy using modulators of notch signalling
#113In situ maturation of dendritic cells
#114Control of indoleamine 2,3 deoxygenase expression and activity
#115Monocyte-derived dendritic cell subsets
#116Immunomodulatory polymeric antigens for treating inflammatory pathologies
#117Methods and compositions for producing antigenic responses
#118Method of preparing immuno-regulatory dendritic cells and the use thereof
#119Selective elimination of cd52and uses thereof
#120In vitro production of dendritic cells from CD14+ monocytes
#121Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use